2844-82-8

Basic information

• Product Name: methoxy-6, phenyl-1, dihydro-3,4 naphtalene
• Synonyms: methoxy-6, phenyl-1, dihydro-3,4 naphtalene
• CAS NO: 2844-82-8
• Molecular Weight: 236.313
• Mol File: 2844-82-8.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: methoxy-6, phenyl-1, dihydro-3,4 naphtalene(CAS DataBase Reference)
• NIST Chemistry Reference: methoxy-6, phenyl-1, dihydro-3,4 naphtalene(2844-82-8)
• EPA Substance Registry System: methoxy-6, phenyl-1, dihydro-3,4 naphtalene(2844-82-8)

Safety Data

• Hazardous Substances Data: 2844-82-8(Hazardous Substances Data)

Upstream product

• 7664-93-9 sulfuric acid 
• 100-58-3 phenylmagnesium bromide 
• 1078-19-9 6-methoxy-3,4-dihydro-1(2H)-naphthalenone 
• 3262-89-3 triphenylboroxine 
• 108-86-1 bromobenzene 
• 591-51-5 phenyllithium 
• 2844-80-6 1,2,3,4,5,8-hexahydro-1-oxo-6-methoxynaphthalene 
• 22117-40-4 1-Hydroxy-1-phenyl-6-methoxy-1,2,3,4-tetrahydronaphthalin 

Downstream Products

• 22117-43-7 6-Hydroxy-1-phenyltetralin 
• 85035-99-0 methoxy-7, phenyl-2, tetrahydro-2,3,4,5 benzo (b) 1H-azepine 
• 78239-11-9 5,7-dibromo-6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalene 
• 78239-12-0 5-bromo-6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalene 
• 85035-94-5 methoxy-7, phenyl-2, dihydro-3,4 benzo (b) 5H-azepine 
• 19353-88-9 6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalene 
• 20915-78-0 6-methoxy-1-phenyl-3,4-dihydronaphthalen-2(1H)-one 
• 27331-47-1 methyl-(5-phenyl-[2]naphthyl)-ether 

Relevant articles and documents

Nickel-Catalyzed Direct Synthesis of Aryl Olefins from Ketones and Organoboron Reagents under Neutral Conditions

Nickel-catalyzed addition of arylboron reagents to ketones results in aryl olefins directly. The neutral condition allows acidic protons of alcohols, phenols, and malonates to be present, and fragile structures are also tolerated.

N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders

β-Aminotetralin derivatives of the formula: STR1 which are ligands for the neuropeptide Y Y5 (NPY5) receptor, methods of preparation and pharmaceutical compositions containing a β-aminotetralin derivative as the active ingredient are described. The β-aminotetralins are useful in the treatment of disorders and diseases associated with NPY receptor subtype Y5.

New method for synthesis of 2-substituted 2,3,4,5-tetrahydrobenzo(b)-1H-azepines

-